vs

Side-by-side financial comparison of OLD REPUBLIC INTERNATIONAL CORP (ORI) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

OLD REPUBLIC INTERNATIONAL CORP is the larger business by last-quarter revenue ($2.4B vs $2.1B, roughly 1.1× Zimmer Biomet). OLD REPUBLIC INTERNATIONAL CORP runs the higher net margin — 13.8% vs 11.4%, a 2.3% gap on every dollar of revenue. On growth, Zimmer Biomet posted the faster year-over-year revenue change (9.3% vs 6.7%). Over the past eight quarters, OLD REPUBLIC INTERNATIONAL CORP's revenue compounded faster (13.2% CAGR vs 3.7%).

Old Republic International Corporation is an American property insurance and title insurance company. The company is headquartered in Chicago, Illinois.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

ORI vs ZBH — Head-to-Head

Bigger by revenue
ORI
ORI
1.1× larger
ORI
$2.4B
$2.1B
ZBH
Growing faster (revenue YoY)
ZBH
ZBH
+2.6% gap
ZBH
9.3%
6.7%
ORI
Higher net margin
ORI
ORI
2.3% more per $
ORI
13.8%
11.4%
ZBH
Faster 2-yr revenue CAGR
ORI
ORI
Annualised
ORI
13.2%
3.7%
ZBH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ORI
ORI
ZBH
ZBH
Revenue
$2.4B
$2.1B
Net Profit
$330.0M
$238.3M
Gross Margin
64.6%
Operating Margin
17.9%
Net Margin
13.8%
11.4%
Revenue YoY
6.7%
9.3%
Net Profit YoY
34.7%
30.5%
EPS (diluted)
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORI
ORI
ZBH
ZBH
Q1 26
$2.4B
$2.1B
Q4 25
$2.4B
$2.2B
Q3 25
$2.4B
$2.0B
Q2 25
$2.2B
$2.1B
Q1 25
$2.1B
$1.9B
Q4 24
$2.0B
$2.0B
Q3 24
$2.3B
$1.8B
Q2 24
$1.9B
$1.9B
Net Profit
ORI
ORI
ZBH
ZBH
Q1 26
$330.0M
$238.3M
Q4 25
$206.5M
$139.4M
Q3 25
$279.5M
$230.9M
Q2 25
$204.4M
$152.8M
Q1 25
$245.0M
$182.0M
Q4 24
$105.3M
$239.5M
Q3 24
$338.9M
$249.1M
Q2 24
$91.8M
$242.8M
Gross Margin
ORI
ORI
ZBH
ZBH
Q1 26
64.6%
Q4 25
64.7%
Q3 25
72.1%
Q2 25
71.5%
Q1 25
71.2%
Q4 24
71.0%
Q3 24
70.5%
Q2 24
71.5%
Operating Margin
ORI
ORI
ZBH
ZBH
Q1 26
17.9%
Q4 25
6.9%
Q3 25
14.6%
17.6%
Q2 25
11.8%
14.4%
Q1 25
14.6%
15.3%
Q4 24
19.2%
Q3 24
18.2%
15.3%
Q2 24
6.1%
18.1%
Net Margin
ORI
ORI
ZBH
ZBH
Q1 26
13.8%
11.4%
Q4 25
8.6%
6.2%
Q3 25
11.5%
11.5%
Q2 25
9.3%
7.4%
Q1 25
11.6%
9.5%
Q4 24
5.3%
11.8%
Q3 24
14.5%
13.7%
Q2 24
4.9%
12.5%
EPS (diluted)
ORI
ORI
ZBH
ZBH
Q1 26
$1.22
Q4 25
$0.82
$0.71
Q3 25
$1.11
$1.16
Q2 25
$0.81
$0.77
Q1 25
$0.98
$0.91
Q4 24
$0.42
$1.18
Q3 24
$1.32
$1.23
Q2 24
$0.35
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORI
ORI
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$424.2M
Total DebtLower is stronger
$7.5B
Stockholders' EquityBook value
$5.9M
$12.7B
Total Assets
$29.6M
$22.7B
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORI
ORI
ZBH
ZBH
Q1 26
$424.2M
Q4 25
$591.9M
Q3 25
$1.3B
Q2 25
$556.9M
Q1 25
$1.4B
Q4 24
$525.5M
Q3 24
$569.0M
Q2 24
$420.1M
Total Debt
ORI
ORI
ZBH
ZBH
Q1 26
$7.5B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
ORI
ORI
ZBH
ZBH
Q1 26
$5.9M
$12.7B
Q4 25
$5.9B
$12.7B
Q3 25
$6.4B
$12.8B
Q2 25
$6.2B
$12.5B
Q1 25
$5.9B
$12.4B
Q4 24
$5.6B
$12.5B
Q3 24
$6.4B
$12.4B
Q2 24
$6.0B
$12.7B
Total Assets
ORI
ORI
ZBH
ZBH
Q1 26
$29.6M
$22.7B
Q4 25
$29.9B
$23.1B
Q3 25
$30.3B
$23.5B
Q2 25
$29.3B
$22.9B
Q1 25
$28.0B
$22.2B
Q4 24
$27.8B
$21.4B
Q3 24
$28.8B
$21.7B
Q2 24
$27.5B
$21.5B
Debt / Equity
ORI
ORI
ZBH
ZBH
Q1 26
0.59×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORI
ORI
ZBH
ZBH
Operating Cash FlowLast quarter
$359.4M
Free Cash FlowOCF − Capex
$245.9M
FCF MarginFCF / Revenue
11.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORI
ORI
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$234.9M
$517.4M
Q3 25
$563.9M
$418.7M
Q2 25
$133.8M
$378.2M
Q1 25
$231.7M
$382.8M
Q4 24
$361.7M
$506.3M
Q3 24
$474.8M
$395.7M
Q2 24
$236.5M
$369.4M
Free Cash Flow
ORI
ORI
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$442.6M
Q3 25
$363.7M
Q2 25
$328.1M
Q1 25
$338.2M
Q4 24
$454.8M
Q3 24
$351.2M
Q2 24
$316.7M
FCF Margin
ORI
ORI
ZBH
ZBH
Q1 26
11.8%
Q4 25
19.7%
Q3 25
18.2%
Q2 25
15.8%
Q1 25
17.7%
Q4 24
22.5%
Q3 24
19.3%
Q2 24
16.3%
Capex Intensity
ORI
ORI
ZBH
ZBH
Q1 26
Q4 25
3.3%
Q3 25
2.7%
Q2 25
2.4%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.4%
Q2 24
2.7%
Cash Conversion
ORI
ORI
ZBH
ZBH
Q1 26
1.51×
Q4 25
1.14×
3.71×
Q3 25
2.02×
1.81×
Q2 25
0.65×
2.48×
Q1 25
0.95×
2.10×
Q4 24
3.43×
2.11×
Q3 24
1.40×
1.59×
Q2 24
2.58×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ORI
ORI

operating$2.2B92%
Other$201.8M8%

ZBH
ZBH

Segment breakdown not available.

Related Comparisons